SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002707
Filing Date
2015-11-16
Accepted
2015-11-16 17:20:30
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q osir-20150930x10q.htm 10-Q 1814100
2 EX-31.1.1 osir-20150930ex3111d2483.htm EX-31.1.1 17296
3 EX-31.2.1 osir-20150930ex3121abf48.htm EX-31.2.1 17653
4 EX-32.1 osir-20150930ex321bccc8e.htm EX-32.1 12208
  Complete submission text file 0001558370-15-002707.txt   9130901

Data Files

Seq Description Document Type Size
5 EX-101.INS osir-20150930.xml EX-101.INS 2670291
6 EX-101.SCH osir-20150930.xsd EX-101.SCH 46666
7 EX-101.CAL osir-20150930_cal.xml EX-101.CAL 59428
8 EX-101.DEF osir-20150930_def.xml EX-101.DEF 161898
9 EX-101.LAB osir-20150930_lab.xml EX-101.LAB 456718
10 EX-101.PRE osir-20150930_pre.xml EX-101.PRE 311389
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32966 | Film No.: 151236300
SIC: 2836 Biological Products, (No Diagnostic Substances)